During the 36‐month follow‐up, serum 25(OH)D levels in all three groups showed an increasing trend but without significant differences from baseline (Figure 4F ). 3.5 Safety of the Treatment During the 3‐year treatment period, no serious AEs were observed.
← all excerpts
Effects of Bisphosphonates on Bone Micro-Architecture of Children With Duchenne Muscular Dystrophy: A Prospective Comparative Study.
1
—
—